...Stock Exchange (HKEX), becoming the world's first publicly listed AI-powered drug delivery company and the first AI-powered large-molecule biopharmaceutical company listed on the Hong Kong market.
Coupled with expanding immunization programs and increasing healthcare access in emerging markets, these factors collectively position injectable drug delivery as the fastest-growing segment in the global pharmaceutical drug delivery market.
Rising adoption of painless and minimally invasive drug delivery systems Growing use of vaccine patches for mass immunization programs Expansion of self-administration therapies for chronic diseases ...
the Company's ability to market, commercialize and achieve broader market acceptance for new products and services offered by the Company; the ability of our biologics and drug delivery partners to ...
The listing makes Metis the first publicly traded AI drug-delivery company globally, and the first Hong Kong-listed biotech focused on AI-driven large-molecule drug delivery, the company said.
Its aim is to develop flexible and biodegradable devices for transdermal drug delivery, providing precise and controlled dosage, high comfort, and compatibility with a wide range of pharmaceuticals.
HUDSON, Wis.--(BUSINESS WIRE)--#CDMO--Phillips Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech ...